MERETEK UBT KIT (W Drug Patent Profile
✉ Email this page to a colleague
When do Meretek Ubt Kit (w patents expire, and when can generic versions of Meretek Ubt Kit (w launch?
Meretek Ubt Kit (w is a drug marketed by Otsuka America and is included in one NDA.
The generic ingredient in MERETEK UBT KIT (W is urea c-13. There are thirty-three drug master file entries for this compound. Additional details are available on the urea c-13 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MERETEK UBT KIT (W?
- What are the global sales for MERETEK UBT KIT (W?
- What is Average Wholesale Price for MERETEK UBT KIT (W?
Summary for MERETEK UBT KIT (W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | MERETEK UBT KIT (W at DailyMed |
US Patents and Regulatory Information for MERETEK UBT KIT (W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka America | MERETEK UBT KIT (W/ PRANACTIN) | urea c-13 | FOR SOLUTION;ORAL | 020586-001 | Sep 17, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
